Latest news with #CMUH
Borneo Post
12-07-2025
- Health
- Borneo Post
Unimas, Taiwan's CMUH host inaugural symposium on cutting-edge medical tech, patient care
Guests, speakers, and participants at the Advances in Medical Technology and Patient Care Symposium 2025 in Kuching pose for a group photo. KUCHING (July 12): Universiti Malaysia Sarawak (Unimas) and Taiwan's China Medical University Hospital (CMUH) co-hosted the inaugural symposium on 'Advances in Medical Technology and Patient Care' today, following a memorandum of understanding signed between the two institutions in 2024. Unimas vice-chancellor Prof Dr Ahmad Hata Rasit, in a speech delivered on his behalf by Dean of the Faculty of Medicine and Health Sciences (FMHS) Prof Dr Asri Said, said the university actively fosters global partnerships to boost research impact and enrich student learning. 'This symposium marks the beginning of what I believe will be a vibrant and enduring academic relationship between CMUH and Unimas,' he said. CMUH International Center Superintendent Dr Chih-Kun Huang said the event not only showcased Taiwan's progress in precision medicine and healthcare innovation but also marked a new chapter of collaboration with Malaysia. 'We look forward to deepening our shared mission of improving health outcomes across borders,' he added. The symposium featured frontier advancements in medical technology and clinical care, with a strong focus on obesity management, cancer treatment, medical artificial intelligence, Parkinson's disease interventions, and atrial fibrillation therapies. During his session, Huang outlined a multidisciplinary approach to obesity treatment that goes beyond conventional methods such as lifestyle modification and pharmacotherapy. He highlighted emerging innovations including novel anti-obesity agents, personalised interventions based on genetics and the microbiome, and less invasive endoscopic bariatric therapies, advancements especially relevant for countries like Malaysia where obesity rates are on the rise. Director of Radiation Oncology at CMUH Dr Chun-Ru Chien, presented the clinical advantages of proton therapy over conventional radiotherapy, noting its ability to precisely target tumours while sparing surrounding healthy tissue, thus reducing side effects. President of the World Federation of Neuroradiological Societies Dr Wan-Yuo Guo, highlighted how medical artificial intelligence (AI) is transforming healthcare by integrating complex data such as imaging, genomics, pathology, and clinical records. He emphasised AI's role in enhancing diagnostic accuracy and enabling predictive, preventive, and personalised medicine. Asri (second left) presents a memento to Huang during the opening of the symposium in Kuching. In the field of neurology, Director of Neurology at CMUH Dr Jui-Cheng Chen, introduced the world's first dual-target Magnetic Resonance-guided Focused Ultrasound (MRgFUS) procedure for Parkinson's disease, a non-invasive treatment that helps relieve symptoms such as tremor and rigidity, particularly for patients unsuited for deep brain stimulation. Also featured was senior consultant in Otorhinolaryngology-Head and Neck Surgery at FMHS Unimas Prof Dr Ing Ping Tang, who reviewed recent advancements in otology implants, including cochlear, bone conduction, middle ear, and auditory brainstem implants. He underscored their growing role in managing complex hearing conditions for patients who gain minimal benefit from conventional hearing aids. From the Faculty of Resource Science and Technology at Unimas, Prof Dr Edmund Sim introduced the Cancer Risk Assessment Toolkit (CARISA), a subscription-based multilingual digital platform for early cancer risk screening. It integrates five disease-specific modules covering breast, nasopharyngeal, cervical, lung, and colorectal cancers, and supports English, Malay, Mandarin, and Iban. Rounding off the event, Director of the Cardiac Arrhythmia Center at CMUH Dr Yen-Nien Lin shared CMUH's integrated approach to atrial fibrillation management, reducing stroke risk and the need for long-term anticoagulation.
Los Angeles Times
19-04-2025
- Health
- Los Angeles Times
Precision Medicine, AI and Smart Exosomes: How Taiwan is Reshaping Global Healthcare
In central Taiwan, one of Asia's most technologically advanced hospitals is setting new standards in precision medicine, digital transformation and biomedical innovation, attracting attention from U.S. clinical researchers and global pharmaceutical partners. Founded in 1958, China Medical University Hospital (CMUH) operates a 2,062-bed facility, managing 200,000 outpatient visits, 11,000 emergency cases and 5,900 surgeries every month. The hospital's consistent innovation has earned it a place on Newsweek's World's Best Hospitals 2023-2024 and World's Best Smart Hospitals 2024-2025. 'Since 2017, we've built a comprehensive digital framework that meets the highest international standards,' says Dr. Wei-Cheng Chen, Chief Secretary of CMUH. The hospital holds four major HIMSS certifications – INFRAM Stage 7, EMRAM Stage 7, AMAM Stage 7 and DIAM Stage 6 – making it the only hospital in Taiwan with this complete set. In 2023, CMUH also topped the Digital Health Indicator, becoming the highest-ranked hospital globally and the only Asian institution to achieve this. This digital infrastructure directly supports CMUH's leadership in CAR-T therapy, medical AI, and exosome research, all areas where the hospital is pushing the boundaries of clinical science. 'We developed the first allogeneic CAR-BiTE GDT therapy for solid tumors, moving beyond liquid cancers into much harder-to-treat areas,' explains Dr. Der-Yang Cho, Superintendent of CMUH. The therapy has already secured FDA approval for clinical trials. Medical AI also plays a central role, supporting diagnostics, risk prediction, and treatment planning across departments. 'From real-time sepsis prediction to AI-assisted ICD coding, our systems help doctors make faster, better decisions every day,' says Chen. Among CMUH's most ambitious innovations is its work with Smart Exosomes, redefining these cellular vesicles as precision drug carriers. 'Our exosomes can deliver DNA, RNA, peptides and proteins directly to targeted organs, from the brain to the heart, enhancing efficacy by up to 90 times while reducing side effects,' says Cho. CMUH's commitment to innovation is reflected in its unmatched 17 awards at the 21st Taiwan National Innovation Awards and 35 honors at the 24th National Healthcare Quality Awards, making it the most awarded hospital in both competitions. 'Following the model of Mayo Clinic, we send our doctors to top 10 global hospitals to master advanced techniques, ensuring that talent drives innovation,' says Cho. 'Talent is very important. We want to lead Taiwan by focusing on both talent and new technology.'
Associated Press
04-03-2025
- Health
- Associated Press
Taiwan's First Hospital to Achieve AMAM Stage 7 Certification!
China Medical University Hospital Sets a New Benchmark in AI-Powered Smart Healthcare TAICHUNG, March 3, 2025 /PRNewswire/ -- China Medical University Hospital (CMUH) has once again achieved a major milestone, becoming Taiwan's first and Asia-Pacific's second medical institution to receive Stage 7 certification in the Analytics Maturity Adoption Model (AMAM) from the Healthcare Information and Management Systems Society (HIMSS). This certification represents the highest global standard in medical data analytics, underscoring CMUH's commitment to AI-driven precision medicine and smart healthcare innovation. CMUH Superintendent Dr. Der-Yang Cho emphasized that this certification reflects the hospital's successful integration of artificial intelligence (AI) and big data analytics into clinical decision-making and hospital management. These advancements have led to more precise diagnostics, more efficient treatments, and significantly reduced patient wait times, enhancing the safety, speed, and personalization of medical care. AI-Driven Precision Medicine: Advancing Critical Care and Surgical Efficiency 1. Smarter Critical Care Management HiThings Tele-ICU: Combining AIoT technology with AI-powered tools such as i.A.M.S (Intelligent Antimicrobial System) and ARDiTeX (Smart Lung Protection), CMUH can now identify high-risk patients and provide personalized treatments for sepsis, acute respiratory distress syndrome (ARDS), critical care nutrition, and sedation delirium. These innovations have successfully reduced ICU mortality rates by 5.4%. AI-Metabolism: AI analyzes genetic information to predict a patient's risk of adverse reactions to specific medications, offering personalized drug and dosage recommendations for safer and more effective treatments. 2. AI-Optimized Surgical Care Enhanced Recovery After Surgery (ERAS): AI automates the entire surgical process, from preoperative assessment to postoperative monitoring, reducing average hospital stays by 23%, accelerating patient recovery, and improving overall efficiency. 3. AI-Powered Medical Records: Saving Time and Improving Accuracy 'MAGI' AI Medical Records Assistant: This AI system instantly transcribes medical staff's spoken notes into structured patient records, reducing documentation time by 85% and allowing healthcare professionals to focus more on patient care. Smart Hospital Management: Boosting Efficiency & Driving Sustainability 1. AI-Driven Diagnosis Coding and Cost Prediction AI-ICD & AI-DRG: These AI-powered systems enhance accuracy in diagnostic coding and cost prediction, ensuring high-quality care while optimizing resource allocation and cost control. 2. Intelligent Supply Chain Management Demand Forecasting AI: Predicts the hospital's medical supply usage, reducing inventory costs by 20.2% and improving resource efficiency. 3. AI-Powered Equipment Maintenance Predictive AI enhances the stability of medical equipment and reduces carbon emissions by 518 kg annually, contributing to environmental sustainability. Leading Taiwan's Digital Healthcare Revolution: Moving Towards Global Smart Healthcare 4.0 Since 2016, CMUH has actively embraced AI-driven digital healthcare transformation, establishing a Big Data Center, an AI Center, and a Digital Transformation Office. In 2019, CMUH became the first hospital in central Taiwan to earn HIMSS INFRAM (IT Infrastructure Maturity) and EMRAM (Electronic Medical Record Maturity) Stage 7 certifications. In 2023, it was the first hospital in Taiwan to renew these certifications and was also honored with the prestigious HIMSS Davies Award of Excellence. That same year, CMUH achieved the highest global score in the Digital Health Indicator (DHI) assessment. In 2024, CMUH received DIAM Stage 6 certification for digital imaging adoption. With its AMAM Stage 7 certification, CMUH is now Taiwan's first and Asia-Pacific's second hospital to achieve this distinction, following Samsung Medical Center in South Korea. Dr. Der-Yang Cho affirmed that CMUH will continue to expand AI applications in healthcare, ensuring Taiwan remains a global leader in Smart Healthcare 4.0 and setting new benchmarks for world-class smart hospitals.
